Use, applicability, and dissemination of patient versions of clinical practice guidelines in oncology in Germany: a qualitative interview study with healthcare providers.

"Declarations Ethics approval and consent to participateThis study was approved by the University Witten/Herdecke Ethics Committee (160/2021). All procedures were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all the participants. Consent for publicationNot applicable. Competing interestsMB was involved in the development of patient versions of oncology in Germany. SBl and MN are representatives of the AWMF, which receives constant financial support from the GGPO and is involved in methodological counselling for CPGs in oncology and other CPGs. MF is a representative publisher of patient versions in oncology in Germany and is involved in the methodological counselling of CPGs and patient versions in oncology. TL is a representative publisher of patient versions of oncology in Germany. CS was involved in the development of patient versions in oncology in Germany until 2019 and is responsible for the development of patient versions of the National Program for Disease Management Guidelines (NDMG) and their methodological refinement. All other authors declare no conflict of interest. Competing interests MB was involved in the development of patient versions of oncology in Germany. SBl and MN are representatives of the AWMF, which receives constant financial support from the GGPO and is involved in methodological counselling for CPGs in oncology and other CPGs. MF is a representative publisher of patient versions in oncology in Germany and is involved in the methodological counselling of CPGs and patient versions in oncology. TL is a representative publisher of patient versions of oncology in Germany. CS was involved in the development of patient versions in oncology in Germany until 2019 and is responsible for the development of patient versions of the National Program for Disease Management Guidelines (NDMG) and their methodological refinement. All other authors declare no conflict of interest."

"Funding The AnImPaLLO project was supported by the Innovation Committee of the Federal Joint Committee (Innovation Fund, grant number: 01VSF20022). Open Access funding enabled and organized by Projekt DEAL."